Utama › Kanser Pankreas › Montana
Kajian klinikal Kanser Pankreas di Montana
6 kajian untuk Kanser Pankreas sedang mencari peserta di lokasi di Montana.
Bandar di Montana
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Saint Joseph Hospital - Cancer Centers - St. Vincent Frontier Cancer Center, Billings
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07409272Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Saint Patrick Hospital - Community Hospital, Missoula
Mengambil pesertaKajian pemerhatian
Umur 50 hingga 75 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT04239573Integrated Cancer Repository for Cancer Research
- Bozeman Health Deaconess Hospital, Bozeman
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 19 hingga 110 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT02012699Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- dan 7 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Mei 2026 · NCT06998940A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Bozeman
- Ohio State University Telemedicine, Miles City
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Feb 2026 · NCT06906562SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Billings
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.